More than 260 attendees, including 60 experts from 58 institutions around the world, convened virtually to discuss focused ultrasound for glioblastomas (GBM).
The purpose of the meeting was to share knowledge, identify gaps in evidence, and create a roadmap for the technical developments, laboratory studies, and clinical trials necessary for focused ultrasound to progress in the treatment of GBM.
Researchers evaluated the long-term benefit of focused ultrasound treatment of essential tremor.
Data from 395 patients revealed hand tremors significantly improved from baseline to 24 months post-treatment, possibly lasting up to 48 months post-treatment and beyond.
The Centers for Medicare and Medicaid Services (CMS) have delayed the implementation of the Medicare Coverage of Innovative Technology (MCIT) program until December 15.
The MCIT will provide immediate, national coverage for breakthrough devices or diagnostics approved by the FDA.
The Foundation and our partners are disappointed by the delay.
